surpass trial tirzepatide for diabetes: on track to current therapy SURPASS-CVOT Published: Large Trial Confirms

The activation of this receptor is known to mediate glucose-stimulated insulin secretion and a glucose-independent release of incretin hormones by intestinal enteroendocrine cells (88)

Pros & Cons Pros: Uncomplicated and user-friendly interface

alone, over 42,000 deaths [archived link] could be prevented each year if everyone who might benefit from taking a GLP-1 RA had access

The Ethical Questions GLP-1 drugs represent a genuine medical breakthrough for many people struggling with obesity and metabolic disease

ABOUT TEENA Teena Pyrcz, RN, graduated from Northeastern University with her Bachelor of Science in Nursing in 2013 and has been building a very rewarding career as a nurse in every specialty from pediatrics to hospice care